Adenylyl cyclase 1 (AC1) inhibitor (IC50 = 2.3 μM). Exhibits some selectivity for AC1 over other AC isoforms, with no significant activity against AC8. Inhibits Ca2+/calmodulin-stimulated cAMP accumulation in hippocampal homogenates. Enhances μ opioid receptor (MOR)-mediated inhibition of AC1 in cellular assays and inhibits development and maintenance of MOR-mediated sensitization of AC1. Active in vivo. Analgesic.
|Storage||Store at -20°C|
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
|Solvent||Max Conc. mg/mL||Max Conc. mM|
Preparing Stock Solutions
The following data is based on the product molecular weight 297.95. Batch specific molecular weights may vary from batch to batch due to solvent of hydration, which will affect the solvent volumes required to prepare stock solutions.
|Concentration / Solvent Volume / Mass||1 mg||5 mg||10 mg|
|1 mM||3.36 mL||16.78 mL||33.56 mL|
|5 mM||0.67 mL||3.36 mL||6.71 mL|
|10 mM||0.34 mL||1.68 mL||3.36 mL|
|50 mM||0.07 mL||0.34 mL||0.67 mL|
References are publications that support the products' biological activity.
Brust et al (2017) Identification of a selective small-molecule inhibitor of type 1 adenylyl cyclase activity with analgesic properties. Sci.Signal. 10 eaah5381 PMID: 28223412
If you know of a relevant reference for ST 034307, please let us know.
View Related Products by Product Action
Keywords: ST 034307, supplier, ST034307, adenylyl, cyclase, inhibitors, inhibits, AC1, active, in, vivo, analgesic, cAMP, Adenylyl, Cyclase, Adenylyl, Cyclase, Tocris Bioscience
Citations for ST 034307
Citations are publications that use Tocris products.
Currently there are no citations for ST 034307. Do you know of a great paper that uses ST 034307 from Tocris? If so please let us know.
ST 034307 Reviews
Average Rating:(Based on 0 Reviews)
Literature in this Area
Schizophrenia is a debilitating psychiatric disorder that affects 1% of the worldwide population. This poster describes the neurobiology of Schizophrenia, as well as highlighting the genetic and environmental factors that play a fundamental role in the etiology of the disease. The current and emerging drug targets are also discussed.